Structures by: Thomas Muthiah P. A.
Total: 52
Bis(3-Chlorothiophene-2-carboxylic acid); 4,4'-bipyridine
2(C5H3ClO2S),C10H8N2
Acta Crystallographica Section E (2016) 72, 10 1362-1365
a=13.538(4)Å b=5.1230(18)Å c=30.167(10)Å
α=90° β=95.968(9)° γ=90°
C76H48Cl4N8O12Pb4S4
C76H48Cl4N8O12Pb4S4
Chemistry Central Journal (2014) 8, 1 39
a=11.6469(4)Å b=12.2824(4)Å c=14.1122(4)Å
α=82.427(2)° β=72.489(2)° γ=84.915(2)°
C80H48Cl4N8O12Pb4S4
C80H48Cl4N8O12Pb4S4
Chemistry Central Journal (2014) 8, 1 39
a=11.5185(2)Å b=12.2250(2)Å c=14.7743(2)Å
α=81.9130(10)° β=72.3490(10)° γ=84.4550(10)°
Trimethoprimium anthracene-9-carboxylate sesquihydrate
C14H19N4O3,C15H9O2,1.5(H2O)
Acta Crystallographica Section C (2018) 74, 4
a=11.1680(5)Å b=16.1913(5)Å c=16.2434(5)Å
α=106.203(3)° β=101.386(3)° γ=90.029(3)°
Trimethoprimium 2,5-dichlorothiophene-3-carboxylate monohydrate
C14H19N4O3,C5HCl2O2S
Acta Crystallographica Section C (2018) 74, 4
a=7.0030(3)Å b=28.2985(15)Å c=11.5070(6)Å
α=90° β=106.080(5)° γ=90°
Trimethoprimium 3-bromothiophene-2-carboxylate monohydrate
C14H19N4O3,C5H2BrO2S,H2O
Acta Crystallographica Section C (2018) 74, 4
a=16.9440(8)Å b=6.8991(3)Å c=19.7206(14)Å
α=90° β=109.773(7)° γ=90°
Trimethoprimium 3-chlorothiophene-2-carboxylate monohydrate
C14H19N4O3,C5H2ClO2S,H2O
Acta Crystallographica Section C (2018) 74, 4
a=16.9730(5)Å b=6.86890(10)Å c=19.6051(5)Å
α=90° β=109.321(3)° γ=90°
Pyrimethaminium 2,5-dichlorothiophene-3-carboxylate
C12H14ClN4,C5HCl2O2S
Acta Crystallographica Section C (2018) 74, 4
a=9.3415(5)Å b=10.2751(6)Å c=11.3730(8)Å
α=63.919(7)° β=85.243(5)° γ=83.689(5)°
Pyrimethaminium 5-bromothiophene-2-carboxylate
C12H14ClN4,C5H2BrO2S
Acta Crystallographica Section C (2018) 74, 4
a=17.0836(6)Å b=15.8893(3)Å c=16.4764(5)Å
α=90° β=116.538(4)° γ=90°
Pyrimethaminium anthracene-9-carboxylate ethanol monosolvate monohydrate
C12H14ClN4,C15H9O2,C2H6O,H2O
Acta Crystallographica Section C (2018) 74, 4
a=9.5195(5)Å b=15.7842(11)Å c=18.8336(8)Å
α=90° β=92.293(4)° γ=90°
Cytosinium 6-chloronicotinate
C4H6N3O,C6H3ClNO2,H2O
Acta Crystallographica Section C (2018) 74, 3
a=19.5314(12)Å b=12.7103(10)Å c=9.8189(5)Å
α=90° β=90° γ=90°
Bis(cytosine)diiodidocadmium(II)
C8H10CdI2N6O2
Acta Crystallographica Section C (2018) 74, 7
a=7.2911(3)Å b=8.1724(3)Å c=12.5766(5)Å
α=89.1090(13)° β=74.2345(13)° γ=87.4815(13)°
Bis(cytosine)bis(nitrato)cadmium(II),
C8H10CdN8O8
Acta Crystallographica Section C (2018) 74, 7
a=12.9213(5)Å b=8.5142(3)Å c=13.6486(6)Å
α=90° β=104.2590(10)° γ=90°
(6-Amino-5-fluorocytosine)aquadibromidozinc(II)--4-amino-5-fluorocytosine (1/1)
C4H6Br2FN3O2Zn,C4H4FN3O
Acta Crystallographica Section C (2018) 74, 7
a=8.0586(4)Å b=10.1383(4)Å c=10.1842(4)Å
α=89.6438(13)° β=68.0189(12)° γ=67.7878(12)°
2,6-Diamino-4-chloropyrimidinium 2-carboxy-3-nitrobenzoate
C4H6ClN4,C8H4NO6
Acta Crystallographica Section C (2017) 73, 7 536-540
a=7.1403(4)Å b=8.6745(6)Å c=11.5730(7)Å
α=93.721(5)° β=93.714(4)° γ=104.230(5)°
2,6-Diamino-4-chloropyrimidinium <i>p</i>-toluenesulfonate
C4H6ClN4,C7H7O3S,H2O
Acta Crystallographica Section C (2017) 73, 7 536-540
a=6.5400(3)Å b=7.2557(4)Å c=15.7696(9)Å
α=81.617(5)° β=89.511(4)° γ=74.154(5)°
N6-benzoyladenine 3-hydroxypyridin-1-ium-2-carboxylate (1/1)
C12H9N5O,C6H5NO3
Acta Crystallographica Section C (2015) 71, 11
a=8.3961(4)Å b=9.8673(5)Å c=11.0680(7)Å
α=66.137(5)° β=83.459(4)° γ=79.546(4)°
N6-benzoyladenine <i>DL</i>-tartaric acid (1/1)
C12H9N5O,C4H6O6
Acta Crystallographica Section C (2015) 71, 11
a=7.5844(7)Å b=10.0175(9)Å c=11.9658(10)Å
α=111.669(8)° β=93.488(7)° γ=98.845(7)°
4-Amino-5-chloro-2,6-dimethylpyrimidine ferrocenecarboxylic acid
C11H10FeO2,C6H8ClN3
Acta Crystallographica Section C (2017) 73, 9
a=20.8783(7)Å b=7.4013(2)Å c=23.2605(8)Å
α=90° β=108.146(4)° γ=90°
5-Fluorouracil--5-bromothiophene-2-carboxylic acid (1/1)
C5H3BrO2S,C4H3FN2O2
Acta Crystallographica Section C (2017) 73, 6 481-485
a=6.8884(4)Å b=9.5036(6)Å c=9.6180(6)Å
α=73.608(2)° β=87.634(2)° γ=69.969(2)°
5-Fluorouracil-thiophene-2-carboxylic acid (1/1)
C4H3FN2O2,C5H4O2S
Acta Crystallographica Section C (2017) 73, 6 481-485
a=6.8304(3)Å b=7.0075(4)Å c=12.3042(6)Å
α=93.348(2)° β=103.0910(10)° γ=115.5660(10)°
Catena-(μ^2^-2-amino-4,6-dimethoxypyrimidine-N,N) -tetra(μ^2^-thiophene-2-carboxylato-O,O')dicopper(II)
C26H21Cu2N3O10S4
Acta Crystallographica Section C (2016) 72, 5 442-450
a=18.5881(4)Å b=10.1091(3)Å c=17.5284(4)Å
α=90° β=111.847(2)° γ=90°
(2-amino-4,6-dimethoxypyrimidine-N)-aqua-chlorido -(thiophene-2-carboxylato-O)cobalt(II) hidrate
C11H14ClCoN3O5S,H2O
Acta Crystallographica Section C (2016) 72, 5 442-450
a=7.2407(2)Å b=7.9326(2)Å c=15.0550(5)Å
α=92.932(2)° β=102.406(2)° γ=102.727(2)°
Bis(4-amino-5-chloro-2,6-dimethylpyrimidinium) tetrathiocyanatozinc(II)--4-amino-5-chloro-2,6-dimethylpyrimidine--water (1/2/2)
2(C6H9ClN3),C4N4S4Zn2,2(C6H8ClN3),2(H2O)
Acta Crystallographica Section C (2016) 72, 4 337-340
a=19.4354(7)Å b=16.7556(6)Å c=15.3266(6)Å
α=90° β=119.4829(11)° γ=90°
<i>N</i>^6^-Benzoyladenine--adipic acid (1/0.5)
C12H9N5O,0.5(C6H10O4)
Acta Crystallographica Section E (2016) 72, 6 805-808
a=6.1776(4)Å b=9.2296(4)Å c=25.7480(15)Å
α=90° β=97.117(6)° γ=90°
Acridine--3-chlorothiophene-2-carboxylic acid (1/1)
C5H3ClO2S,C13H9N
Acta Crystallographica Section E (2016) 72, 5 659-662
a=7.3371(4)Å b=8.3286(5)Å c=13.3819(8)Å
α=107.577(5)° β=97.706(5)° γ=93.953(5)°
5-fluoro-cytosinium 3-hydroxypicolinate
C4H5FN3O,C6H4NO3
Acta Crystallographica Section E (2014) 70, 11 328-330
a=12.6487(4)Å b=7.0786(2)Å c=23.7200(6)Å
α=90.00° β=90.00° γ=90.00°
4-Amino-5-chloro-2,6-dimethylpyrimidinium thiophene-2,5-dicarboxylate
C6H9ClN3,C6H3O4S
Acta Crystallographica Section E (2016) 72, 7 1043-1046
a=7.9948(3)Å b=11.3928(4)Å c=15.7757(6)Å
α=90° β=98.520(2)° γ=90°
2,6-Diamino-4-chloropyrimidin-1-ium 5-chlorosalicylate
C4H6ClN4,C7H4ClO3
Acta Crystallographica Section E (2018) 74, 2 237-241
a=13.9203(14)Å b=7.0285(6)Å c=15.4294(14)Å
α=90° β=114.544(12)° γ=90°
Bis(2,6-diamino-4-chloropyrimidin-1-ium) naphthalene-1,5-disulfonate
2(C4H6ClN4),C10H6O6S22
Acta Crystallographica Section E (2018) 74, 2 237-241
a=9.1696(4)Å b=13.0848(7)Å c=9.9663(5)Å
α=90° β=90.526(5)° γ=90°
<i>N</i>^6^-benzoyladeninium nitrate
C12H10N5O,NO3
Acta Crystallographica Section E (2016) 72, 2 140-143
a=12.7949(10)Å b=10.5639(9)Å c=9.6676(6)Å
α=90° β=90° γ=90°
5-Fluorocytosinium picrate
C4H5FN3O,C6H2N3O7
Acta Crystallographica Section E (2017) 73, 3 361-364
a=7.7463(15)Å b=13.235(3)Å c=25.642(5)Å
α=90° β=90° γ=90°
<i>N</i>^6^-Benzoyladenine--4-hydroxybenzoic acid (1/1)
C12H9N5O,C7H6O3
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 3 383-386
a=14.7579(5)Å b=6.7930(3)Å c=17.2873(5)Å
α=90° β=91.287(3)° γ=90°
Pyrimethamine
C12H13ClN4
Acta Crystallographica Section E (2002) 58, 8 o817-o818
a=9.5854(15)Å b=10.8061(17)Å c=12.484(2)Å
α=79.059(13)° β=89.440(15)° γ=82.372(14)°
Diaquadinitratothiabendazolecopper(II)
C10H11CuN5O8S
Acta Crystallographica Section E (2002) 58, 8 m392-m395
a=7.580(4)Å b=20.065(5)Å c=10.606(2)Å
α=90° β=109.51(3)° γ=90°
Trimethoprim perchlorate
C14H19N4O31,ClO41
Acta Crystallographica Section E (2002) 58, 1 o59-o61
a=9.672(2)Å b=10.2190(10)Å c=9.651(2)Å
α=91.190(10)° β=107.180(10)° γ=72.44(2)°
Trimethoprim salicylate methanol solvate
C14H19N4O31,C7H5O31,CH4O
Acta Crystallographica Section E (2002) 58, 2 o180-o182
a=10.0139(19)Å b=10.2600(19)Å c=11.984(9)Å
α=105.93(3)° β=109.17(5)° γ=92.50(2)°
Thiabendazolium perchlorate
C10H8N3S1,ClO41
Acta Crystallographica Section E (2002) 58, 4 o426-o428
a=14.121(15)Å b=5.245(2)Å c=17.384(15)Å
α=90° β=108.99(11)° γ=90°
N^6^-benzyladenine hydrobromide
C12H12BrN5
Acta Crystallographica Section E (2001) 57, 9 o881-o883
a=18.581(3)Å b=5.163(2)Å c=13.344(3)Å
α=90° β=93.71(2)° γ=90°
Trimethoprim sulfate trihydrate
2C14H19N4O31,SO41,3H2O
Acta Crystallographica Section E (2001) 57, 12 o1179-o1182
a=7.2290(10)Å b=23.2420(10)Å c=20.3730(10)Å
α=90° β=98.590(10)° γ=90°
8-Hydroxyquinoline-5-sulfonic acid nickel(II)
C9H13NNiO8S,H2O
Acta Crystallographica Section E (2001) 57, 12 m591-m594
a=7.366(2)Å b=9.000(2)Å c=21.456(2)Å
α=90° β=93.73(2)° γ=90°
Cytosine Cadmium Dibromide
C8H10Br2CdN6O2
Acta Crystallographica Section E (2001) 57, 12 m558-m560
a=7.874(2)Å b=12.624(3)Å c=7.117(3)Å
α=105.87(4)° β=92.67(3)° γ=87.93(3)°
8-hydroxyquinoline salicylate-salicylic acid complex
C23H19NO7
Acta Crystallographica Section C (1998) 54, 4 539-540
a=9.8899(13)Å b=10.1168(10)Å c=10.5673(9)Å
α=86.702(9)° β=88.222(11)° γ=72.206(9)°
Thiabendazole nitrate
C10H8N3S1,NO31
Acta Crystallographica Section C (1998) 54, 12 1905-1907
a=4.8509(15)Å b=14.0214(12)Å c=16.671(3)Å
α=90° β=97.43(2)° γ=90°
Trimethorprim maleate
C14H19N4O3,C4H3O4
Acta Crystallographica Section C (2001) 57, 4 459-461
a=28.485(2)Å b=12.964(3)Å c=5.413(2)Å
α=90° β=93.27(3)° γ=90°
Pyrimethaminium pyridine-3-sulfonate
C12H14ClN4,C5H4NO3S
Acta Crystallographica Section E (2010) 66, 8 o2121-o2122
a=10.4525(17)Å b=12.200(2)Å c=16.539(3)Å
α=81.130(9)° β=83.580(9)° γ=68.649(8)°
2,6,6-Trimethylcyclohex-2-enecarboxylic acid
C10H16O2
Acta Crystallographica Section E (2012) 68, 2 o536
a=7.68170(10)Å b=10.4137(2)Å c=13.4421(2)Å
α=90° β=112.9240(10)° γ=90°
Trimethoprimium 5-methylthiophene-2-carboxylate monohydrate
C14H19N4O3,C6H5O2S,H2O
Acta Crystallographica Section C (2018) 74, 4
a=6.9417(3)Å b=9.8281(6)Å c=16.2754(10)Å
α=90.813(5)° β=90.376(4)° γ=99.084(4)°
Bis(pyrimethaminium) naphthalene-1,5-disulfonate
2(C12H14ClN4),C10H6O6S22
Acta Crystallographica Section C (2018) 74, 4
a=10.7421(3)Å b=11.7053(4)Å c=24.5947(8)Å
α=85.450(3)° β=87.699(3)° γ=63.459(3)°
2-amino-5-bromo-4-hydroxy-6-methylpyrimidinium hydrogensulfate
C5H7BrN3O,HO4S
Acta Crystallographica Section C (2018) 74, 3
a=16.1671(4)Å b=4.87860(10)Å c=12.0863(3)Å
α=90° β=96.026(2)° γ=90°
Trimethoprimium ferrocenecarboxylate
C14H19N4O3,C11H9FeO2
Acta Crystallographica Section C (2017) 73, 9
a=10.3583(2)Å b=13.1393(3)Å c=17.7722(4)Å
α=90° β=92.291(2)° γ=90°
Trimethoprim glutarate
C14H19N4O31,C5H7O41
Acta Crystallographica Section E (2001) 57, 12 o1206-o1208
a=12.017(2)Å b=10.090(3)Å c=8.804(4)Å
α=84.430(3)° β=94.900(3)° γ=104.590(3)°